Coang, Nilda M.

HRN: 15-56-98  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
09/09/2022
09/16/2022
IV
1.5grams
Q6H
CAP HR
Waiting Final Action 
07/08/2023
CEFUROXIME 500MG (TAB)
07/08/2023
07/14/2023
PO
1 Tab
BID
Thinly MSAF
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: